The present invention relates to amide compounds of general formula I ##STR00001## wherein the groups and residues A, B, b, W, X, Y, Z, R.sup.1, R.sup.2 and R.sup.3 have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one amide according to the invention. In view of the MCH receptor-antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.